Where do Relmada Therapeutics, Inc.'s ratios come from?

Every ratio is computed from Relmada Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Returns
Return on equity	-48.8%+45.2pp	-94%+103pp	-196.8%-21.7pp	-175.1%-14.9pp	-160.3%-27.9pp
Return on assets	-44.8%+37.3pp	-82.1%+77.0pp	-159.1%-12.0pp	-147.2%-12.1pp	-135.1%-23.5pp
Liquidity
Current ratio	18.3×+3.6×	14.6×+11.8×	2.9×-1.2×	4.1×-1.2×	5.3×+0.8×
Quick ratio	18.3×+3.6×	14.6×+11.8×	2.9×-1.2×	4.1×-1.2×	5.3×+0.8×
Cash ratio	0.8×+0.2×	0.5×+0.3×	0.3×0.0×	0.3×0.0×	0.2×-0.2×
Per Share
Book value per share	$2.53+15.3%	$2.19+668%	$0.29-40.6%	$0.48-34.9%	$0.74-37.3%
Valuation
Market capitalization	$677.17M+2,907%	$354.2M+431%	$66.72M+240%	$19.65M+119%	$8.96M-42.9%
Price / book	3.1×+2.1×	4.1×-3.0×	7×+5.8×	1.2×+0.8×	0.4×0.0×
Earnings yield	-8.7%+327pp	-16.2%+68.0pp	-84.2%+261pp	-345.2%+500pp	-844.8%-335pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Relmada Therapeutics, Inc.'s ratios come from?: Every ratio is computed from Relmada Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.